Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial
肾细胞癌中酪氨酸激酶抑制剂和 nivolumab 单药治疗的免疫生物标志物评估:I 期 TRIBE 试验
期刊:ImmunoOncology and Technology
影响因子:
doi:10.1016/j.iotech.2024.100712
K S Shohdy, M Pillai, K S Abbas, J Allison, T Waddell, E Darlington, S Mohammad, S Hood, S Atkinson, K Simpson, D Morgan, P Nathan, E Kilgour, C Dive, F Thistlethwaite